This week, P4A's podcast will cover Luxturna's CHMP recommendation, Novartis' restructuring plans and Alexion's acquisition of Syntimmune.
Presenter: Max Rex
Contributor: Aparna Krishnan
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
